April 10, 2017

Salk’s research center on aging receives additional $3 million award from Glenn Foundation for Medical Research

Salk News


Salk’s research center on aging receives additional $3 million award from Glenn Foundation for Medical Research

LA JOLLA—The Salk Institute has received a $3 million award from the Glenn Foundation for Medical Research for the second time in 4 years, enabling the Institute to continue investigating the biology of normal human aging and age-related diseases.

The award will support the work of the Paul F. Glenn Center for Biology of Aging Research at the Salk Institute, which was established in January 2009 with a $5 million award from the Glenn Foundation. In 2014, the foundation continued its support of the center with the first $3 million award. The center draws from 13 of Salk’s leading laboratories specializing in genetic analysis, stem cell biology and metabolism research.

“Understanding the effects of biological aging is the first step in the discovery of treatments to delay or cure age-related disease,” says Glenn Foundation President Mark R. Collins. “Aging is the climate change of human biology.”

The continuing support of the Glenn Foundation, along with Salk’s uniquely collaborative culture, positions the center to advance aging research rapidly and to shed light on ways to stave off a variety of age-related diseases, such as cancer, cardiovascular disease, diabetes and Alzheimer’s.

The Salk center focuses on a three-level approach: whole systems biology, organ biology and cellular aging biology. Expertise in all three areas is required to understand aging, age-related disease and the difference between healthy and pathological aging.

The center is led by Professor Jan Karlseder of Salk’s Molecular and Cell Biology Laboratory. Karlseder seeks to understand the functions of telomeres, which are the protein-DNA complexes at the ends of linear chromosomes and are crucial in DNA replication, tumor suppression and aging. Recently, Karlseder’s lab discovered that, in stem cells, a balance of telomere elongation and trimming maintains telomere length.

“Learning how to influence this mechanism to maintain telomere length could help ameliorate some of the effects of aging,” says Karlseder, holder of Salk’s Donald and Darlene Shiley Chair. “Support by the Glenn Foundation to the Salk Institute provides a unique tool for the collaboration of investigators with different backgrounds toward the unified goal of understanding molecular pathways affecting the aging process.”

The center will use the Glenn Foundation award to further support research into the biology of normal aging with the objective of developing interventions to delay its onset and progression, thereby extending the human healthspan. The center was the third of eight institutions to join the Glenn Consortium for Research in Aging, which includes Harvard Medical School, MIT’s Department of Biology, Princeton University and the Stanford University School of Medicine.

About the Glenn Foundation for Medical Research:
Since its founding in 1965 the Glenn Foundation for Medical Research has supported basic research to better understand the biology that governs normal human aging and its related physiological decline, with the objective of developing interventions that will extend the healthy years of human life.

About the Salk Institute for Biological Studies:
Every cure has a starting point. The Salk Institute embodies Jonas Salk’s mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer’s, aging or diabetes, Salk is where cures begin. Learn more at: salk.edu.

For More Information

Office of Communications
Tel: (858) 453-4100
press@salk.edu